ETR:AFX Carl Zeiss Meditec (AFX) Stock Price, News & Analysis €56.60 -1.10 (-1.91%) As of 04/17/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Carl Zeiss Meditec Stock (ETR:AFX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Carl Zeiss Meditec alerts:Sign Up Key Stats Today's Range€55.55▼€57.3550-Day Range€48.74▼€69.6052-Week Range€54.60▼€123.75Volume109,282 shsAverage Volume94,405 shsMarket Capitalization$5.27 billionP/E Ratio30.25Dividend Yield1.94%Price TargetN/AConsensus RatingN/A Company OverviewCarl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.Read More… Receive AFX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter. Email Address AFX Stock News HeadlinesEQS-Adhoc: Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25April 15 at 4:37 AM | markets.businessinsider.comCarl Zeiss Meditec AG: ZEISS receives FDA clearance for INTRABEAM 700April 9, 2025 | finanznachrichten.deTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that could benefit.April 18, 2025 | Brownstone Research (Ad)Carl Zeiss Meditec's (ETR:AFX) Dividend Will Be Reduced To €0.60March 22, 2025 | finance.yahoo.comJ.P. Morgan Sticks to Their Sell Rating for Carl Zeiss Meditec (0DHC)March 13, 2025 | markets.businessinsider.comEQS-News: ZEISS VISUMAX 800 with SMILE pro software receives approval in ChinaFebruary 27, 2025 | markets.businessinsider.comCarl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Smaller Dividend Than Last YearFebruary 16, 2025 | uk.finance.yahoo.comCarl Zeiss Meditec's Profit Falls; Warns of Challenging Macroeconomic EnvironmentFebruary 12, 2025 | marketwatch.comSee More Headlines AFX Stock Analysis - Frequently Asked Questions How have AFX shares performed this year? Carl Zeiss Meditec's stock was trading at €45.52 at the beginning of 2025. Since then, AFX shares have increased by 24.3% and is now trading at €56.60. View the best growth stocks for 2025 here. What other stocks do shareholders of Carl Zeiss Meditec own? Based on aggregate information from My MarketBeat watchlists, some other companies that Carl Zeiss Meditec investors own include Intel (INTC), Meta Platforms (META), NVIDIA (NVDA), Volkswagen (VOW3), AbbVie (ABBV), Chevron (CVX) and Siemens Aktiengesellschaft (SIE). Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolETR:AFX CIKN/A Webwww.zeiss.com Phone+49-3641-2200FaxN/AEmployees4,950Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)€1.87 Trailing P/E Ratio30.25 Forward P/E Ratio19.38 P/E Growth2.83Net Income$185.59 million Net Margins7.03% Pretax MarginN/A Return on Equity8.49% Return on Assets7.03% Debt Debt-to-Equity Ratio7.41 Current Ratio2.13 Quick Ratio2.47 Sales & Book Value Annual Sales$2.64 billion Price / Sales2.00 Cash Flow€0.04 per share Price / Cash Flow1,398.28 Book Value€22.92 per share Price / Book2.47Miscellaneous Outstanding Shares93,178,085Free FloatN/AMarket Cap$5.27 billion OptionableNot Optionable Beta0.98 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (ETR:AFX) was last updated on 4/18/2025 by MarketBeat.com Staff From Our Partners🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carl Zeiss Meditec AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Carl Zeiss Meditec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.